Teladoc Health, Inc. (NYSE:TDOC) Short Interest Update

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 22,710,000 shares, a decrease of 13.5% from the November 30th total of 26,240,000 shares. Based on an average daily trading volume, of 5,360,000 shares, the short-interest ratio is currently 4.2 days.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.95% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Signaturefd LLC raised its stake in shares of Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,715 shares during the period. International Assets Investment Management LLC purchased a new position in Teladoc Health in the 2nd quarter valued at about $29,000. Blue Trust Inc. grew its stake in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health during the second quarter worth about $46,000. Finally, Benjamin F. Edwards & Company Inc. lifted its stake in shares of Teladoc Health by 209.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider's stock worth $49,000 after acquiring an additional 3,396 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on TDOC. Piper Sandler reissued an "overweight" rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Jefferies Financial Group raised their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a "hold" rating in a report on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a report on Friday, November 1st. Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. Finally, TD Cowen reduced their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $12.24.

Teladoc Health Trading Down 1.5 %

Teladoc Health stock traded down $0.14 during midday trading on Monday, reaching $9.31. The stock had a trading volume of 4,188,510 shares, compared to its average volume of 5,486,226. The stock's 50-day simple moving average is $9.84 and its 200 day simple moving average is $9.06. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market capitalization of $1.60 billion, a PE ratio of -1.61 and a beta of 0.97.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analysts' expectations of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Analysts expect that Teladoc Health will post -1.16 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.